Skip to content
Use caution Drug recall · FDA · Published July 13, 2023

Sun Pharmaceutical Methylphenidate Tablets Recall: Metal in Tablets

Sun Pharmaceutical recalls 20mg methylphenidate tablets with metal embedded in some tablets. This could cause injury if swallowed. Consumers should contact the company for details.

🇺🇸 FDA recall #D-0940-2023DrugSun Pharmaceutical ›
Take action

Contact the company

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way · Princeton, NJ 08540-6620
✎ GovInfoNow plain-language explainer

Sun Pharmaceutical is recalling 20mg methylphenidate tablets that may contain metal fragments. Swallowing metal could cause injury, so affected users should stop using the product and contact the company. Read more at govinfonow.com/recall/33374-sun-pharmaceutical-methylphenidate-tablets-recall-metal-in-tablets.

Source Summary by GovInfoNow · govinfonow.com/recall/33374-sun-pharmaceutical-methylphenidate-tablets-recall-metal-in-tablets · Updated August 17, 2026 · FDA enforcement record: FDA #D-0940-2023

Cite this page

“Sun Pharmaceutical Methylphenidate Tablets Recall: Metal in Tablets.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33374-sun-pharmaceutical-methylphenidate-tablets-recall-metal-in-tablets. Based on FDA recall #D-0940-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0940-2023%22&limit=1).

The FDA announced on July 13, 2023, that Sun Pharmaceutical Industries Inc. is recalling Methylphenidate Hydrochloride Tablets, USP 20mg due to the presence of a metal foreign substance embedded in the tablets. This voluntary Class II recall affects 7,313 bottles distributed nationwide.

How to tell if you have it

  • Brand: Sun Pharmaceutical
  • Product: Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle
  • Manufacturer: Ohm Laboratories Inc., New Brunswick, NJ 08901
  • Distributor: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512
  • NDC: 57664-230-88
  • Lot Code: AC74459
  • Expiration Date: 07/31/2024
  • Quantity: 7,313 bottles

The hazard

The recall involves the presence of a foreign substance, specifically metal embedded in a tablet. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Sun Pharmaceutical Industries Inc. has 93 other recalls on record since May 21, 2013. Other recent recalls of similar products include Sun Pharmaceutical Nystatin Cream Recall (Sept. 14, 2026), Sun Pharmaceutical Carbamazepine Tablets Recall (Aug. 3, 2026), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026). Other recent recalls of similar products include Guardian Drug Family Wellness Antacid Tablets Recall (May 28, 2026), Guardian Market Basket Antacid Recall (May 28, 2026), and Guardian Drug TopCare Antacid Tablets Recall (May 28, 2026).

How to tell if you have this one

Check for the product name 'Methylphenidate Hydrochloride Tablets, USP 20mg', NDC 57664-230-88, lot AC74459, manufactured by Ohm Laboratories. The product was distributed by Sun Pharmaceutical in the US.

  • Brand
    Sun Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC code 57664-230-88 and lot number AC74459 on the packaging.

  2. Contact Sun Pharmaceutical

    Reach out to Sun Pharmaceutical for instructions on what to do with the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: Jul 13, 202312. FDA classified it Class II: Jul 24, 202323. Published in FDA’s Enforcement Report: Aug 2, 202334. FDA terminated the recall: Feb 12, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sun Pharmaceutical recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0940-2023 (July 13, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0940-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA